Free Trial

Wells Fargo & Company MN Buys 12,799 Shares of MetLife, Inc. (NYSE:MET)

MetLife logo with Finance background
Remove Ads

Wells Fargo & Company MN boosted its stake in MetLife, Inc. (NYSE:MET - Free Report) by 0.8% in the fourth quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 1,651,944 shares of the financial services provider's stock after purchasing an additional 12,799 shares during the period. Wells Fargo & Company MN owned about 0.24% of MetLife worth $135,261,000 at the end of the most recent reporting period.

Several other large investors have also bought and sold shares of MET. Geode Capital Management LLC raised its position in shares of MetLife by 1.3% in the 4th quarter. Geode Capital Management LLC now owns 11,931,536 shares of the financial services provider's stock worth $973,901,000 after acquiring an additional 158,107 shares in the last quarter. Norges Bank bought a new position in shares of MetLife during the 4th quarter worth approximately $730,716,000. Bank of New York Mellon Corp grew its position in shares of MetLife by 109.2% during the 4th quarter. Bank of New York Mellon Corp now owns 8,826,658 shares of the financial services provider's stock worth $722,727,000 after buying an additional 4,606,748 shares during the period. Clearbridge Investments LLC increased its stake in shares of MetLife by 43.7% in the 4th quarter. Clearbridge Investments LLC now owns 5,663,177 shares of the financial services provider's stock valued at $463,701,000 after acquiring an additional 1,723,461 shares in the last quarter. Finally, Nordea Investment Management AB lifted its position in shares of MetLife by 16.8% during the 4th quarter. Nordea Investment Management AB now owns 4,238,087 shares of the financial services provider's stock valued at $347,735,000 after acquiring an additional 608,224 shares during the period. 94.99% of the stock is owned by institutional investors.

Remove Ads

MetLife Stock Performance

Shares of NYSE:MET traded down $1.25 during midday trading on Friday, reaching $69.86. The company had a trading volume of 1,105,071 shares, compared to its average volume of 3,394,048. The stock has a market cap of $47.59 billion, a P/E ratio of 11.71, a P/E/G ratio of 0.65 and a beta of 0.89. The company's 50 day moving average price is $80.59 and its 200 day moving average price is $82.52. The company has a current ratio of 0.16, a quick ratio of 0.16 and a debt-to-equity ratio of 0.54. MetLife, Inc. has a 52-week low of $65.21 and a 52-week high of $89.05.

MetLife (NYSE:MET - Get Free Report) last released its earnings results on Wednesday, February 5th. The financial services provider reported $2.08 earnings per share (EPS) for the quarter, missing analysts' consensus estimates of $2.13 by ($0.05). MetLife had a return on equity of 20.42% and a net margin of 6.19%. As a group, sell-side analysts anticipate that MetLife, Inc. will post 9.65 EPS for the current fiscal year.

Wall Street Analysts Forecast Growth

MET has been the topic of a number of research analyst reports. StockNews.com cut shares of MetLife from a "buy" rating to a "hold" rating in a research report on Thursday, January 9th. Keefe, Bruyette & Woods lowered their target price on MetLife from $98.00 to $95.00 and set an "outperform" rating on the stock in a research report on Wednesday. Piper Sandler lifted their price target on shares of MetLife from $92.00 to $94.00 and gave the company an "overweight" rating in a research report on Wednesday, April 2nd. Morgan Stanley decreased their price target on shares of MetLife from $109.00 to $94.00 and set an "overweight" rating for the company in a research note on Thursday. Finally, Wells Fargo & Company reduced their price objective on shares of MetLife from $97.00 to $91.00 and set an "overweight" rating for the company in a report on Thursday. Two analysts have rated the stock with a hold rating and thirteen have given a buy rating to the stock. According to data from MarketBeat, the stock presently has an average rating of "Moderate Buy" and a consensus price target of $93.00.

Check Out Our Latest Research Report on MET

About MetLife

(Free Report)

MetLife, Inc, a financial services company, provides insurance, annuities, employee benefits, and asset management services worldwide. It operates through six segments: Retirement and Income Solutions; Group Benefits; Asia; Latin America; Europe, the Middle East and Africa; and MetLife Holdings. The company offers life, dental, group short-and long-term disability, individual disability, pet insurance, accidental death and dismemberment, vision, and accident and health coverages, as well as prepaid legal plans; administrative services-only arrangements to employers; and general and separate account, and synthetic guaranteed interest contracts, as well as private floating rate funding agreements.

Featured Articles

Institutional Ownership by Quarter for MetLife (NYSE:MET)

Should You Invest $1,000 in MetLife Right Now?

Before you consider MetLife, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and MetLife wasn't on the list.

While MetLife currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

A Beginner's Guide to Investing in Cannabis Cover

Unlock your free copy of MarketBeat's comprehensive guide to pot stock investing and discover which cannabis companies are poised for growth. Plus, you'll get exclusive access to our daily newsletter with expert stock recommendations from Wall Street's top analysts.

Get This Free Report
Like this article? Share it with a colleague.
Remove Ads

Featured Articles and Offers

Congress Bought THESE Stocks as Tariffs Tanked the Market

Congress Bought THESE Stocks as Tariffs Tanked the Market

Reports of congressional buying and selling during the tariff meltdown are coming in; find out which companies members of Congress bought and sold.

Related Videos

5 Stocks to BUY Now as Tariff Uncertainty Fades
Donald Trump Owns These 7 Stocks, Should You?
Donald Trump Owns These 7 Stocks, Should You?

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines

Remove Ads